Skip to Main Content (Press Enter)

Logo HUMANITAS
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Persone
  • Pubblicazioni
  • Competenze

UNI-FIND
Logo HUMANITAS

|

UNI-FIND

hunimed.eu
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Persone
  • Pubblicazioni
  • Competenze
  1. Pubblicazioni

Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience

Articolo
Data di Pubblicazione:
2021
Abstract:
YBackground: En bloc resection (ERBT) is a valid alternative to piecemeal resection for non-muscle-invasive bladder cancer (NMIBC), guaranteeing pathological outcomes. However, very few studies investigated long-term oncological outcomes of ERBT.Objective: To report long-term oncological outcome of ERBT.Design, setting, and participants: This is a retrospective analysis of prospectively collected data. We included patients who underwent ERBT from June 2010 to February 2014, and were diagnosed with NMIBC at pathology evaluation.Outcome measurements and statistical analysis: The primary study endpoint was recurrence-free survival at 5 yr. Secondary outcomes were presence of detrusor muscle, recurrence rate at the first follow-up cystoscopy, progression to muscle-invasive bladder cancer (MIBC) at 5 yr, and factors associated with long-term oncological outcomes. Kaplan-Meier curves were used to describe recurrence-free survival time. A univariate analysis was used to investigate factors associated with recurrence.Results and limitations: Overall, 74 patients were included in this study. The median age was 71 (66-76) yr. Most of the patients presented with only one bladder tumor, and the median tumor diameter was 2 (interquartile range [IQR] 1-2.5) cm. After histopathological examination, eight, 35, and 31 patients were diagnosed with low-, intermediate-, and high-risk disease, respectively. All the en bloc resected tumors showed the presence of detrusor muscle. The median follow-up was 72 (IQR 66-90) mo. The recurrence rate at the first follow-up cystoscopy was 5.4% (four out of 74 patients). Overall, 57 (77%) patients were free of recurrence at 5 yr. No progression to MIBC was observed: progression-free survival was 100%. Limitations include retrospective design and small size.Conclusions: Our findings showed that ERBT for NMIBC presents an optimal long-term oncological outcome. Further studies with larger cohorts are necessary for confirming our preliminary results and for a direct comparison with the traditional piecemeal resection.Patient summary: In case of superficial bladder tumors, transurethral resection of the entire tumor and its base in one piece seems to provide good long-term results in terms of recurrence and progression rates. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
En bloc resection; High grade non–muscle-invasive bladder cancer; Long-term outcomes; Non–muscle-invasive bladder cancer; Transurethral resection of bladder tumor
Elenco autori:
Paciotti, Marco; Casale, Paolo; Colombo, Piergiuseppe; Fasulo, Vittorio; Saita, Alberto; Lughezzani, Giovanni; Contieri, Roberto; Buffi, Nicolò Maria; Lazzeri, Massimo; Guazzoni, Giorgio; Hurle, Rodolfo
Autori di Ateneo:
Buffi Nicolomaria
Colombo Piergiuseppe
Fasulo Vittorio
Lughezzani Giovanni
Paciotti Marco
Link alla scheda completa:
https://iris.hunimed.eu/handle/11699/61715
Pubblicato in:
EUROPEAN UROLOGY OPEN SCIENCE
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.9.3.0